{"meshTagsMajor":["Immunotherapy","Genetic Therapy"],"meshTags":["Tumor Cells, Cultured","Receptors, Interleukin-6","Interleukin-6","T-Lymphocytes","Immunotherapy","Genetic Therapy","Antigens, CD","Lymphocytes, Tumor-Infiltrating","Humans","Melanoma"],"meshMinor":["Tumor Cells, Cultured","Receptors, Interleukin-6","Interleukin-6","T-Lymphocytes","Antigens, CD","Lymphocytes, Tumor-Infiltrating","Humans","Melanoma"],"organisms":["9606"],"publicationTypes":["Clinical Trial","Clinical Trial, Phase I","Clinical Trial, Phase II","Journal Article","Research Support, Non-U.S. Gov\u0027t"],"title":"Immunogene therapy of human melanoma. Phase I/II clinical trial.","pubmedId":"10026927"}